Omniab (OABI) Bɛn Dɛŋɛn Akɔc
Bɛ̈ny cɔk aya$4.60Aciic 25 Sep 2026 19:59 UTC
Change-3.97%
AI forecast: OABI
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
OmniAb is a biotechnology company that provides a platform for the discovery of therapeutic antibodies. The company gives pharmaceutical industry partners access to genetically modified animals capable of producing human antibodies, and it offers high-throughput screening technologies and computational platforms for antigen development. OmniAb serves biopharmaceutical companies and research institutions worldwide.
